RecruitingEarly Phase 1NCT04734106

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

A Double-Blind, Placebo-Controlled Study to Establish the Safety and Efficacy of Super-Concentrated, Freeze-Dried Aloe Vera in the Management of the Symptoms of Interstitial Cystitis


Sponsor

Wake Forest University Health Sciences

Enrollment

30 participants

Start Date

Feb 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to assess the safety and efficacy of super-concentrated, freeze-dried aloe vera capsules for treatment of interstitial cystitis.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Desert Harvest Aloe Vera Capsules and Placebo Capsules for people with bladder pain syndrome, chronic interstitial cystitis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDesert Harvest Aloe Vera Capsules

600 mg pure, freeze-dried aloe vera super-concentrate with a minimum of 200 mg glycosaminoglycan per capsule.

OTHERPlacebo Capsules

550mg of Avicel microcrystalline cellulose per two-piece, hard-shelled gelatin capsule.


Locations(1)

Wake Forest Baptist Hospital

Winston-Salem, North Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04734106


Related Trials